Leaflet LAGEVRIO 200mg hard capsules

Indicated for: COVID-19

Substance: molnupiravir (antiviral)

ATC: J05AB18 (Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors)

Molnupiravir is an antiviral medication used for the treatment of COVID-19 in patients with mild to moderate disease who are at high risk of progressing to severe illness. It works by inhibiting the replication of the SARS-CoV-2 virus, thereby reducing viral load.

The medication is taken orally, usually twice daily for five days. It is effective in reducing the risk of hospitalization and death in high-risk patients.

Side effects may include nausea, diarrhea, dizziness, and headache. Currently, its use is limited to certain patient groups, and its long-term safety is still under investigation.

Consult your doctor to discuss whether Molnupiravir is suitable for you. It is important to follow the prescribed dosage and adhere to all medical recommendations.